Roth Capital Starts Fate Therapeutics (FATE) at Buy

September 22, 2016 8:16 AM EDT
Get Alerts FATE Hot Sheet
Price: $2.98 -1.32%

Rating Summary:
    7 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 21 | Down: 36 | New: 11
Trade FATE Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Roth Capital initiated coverage on Fate Therapeutics (NASDAQ: FATE) with a Buy rating and a price target of $8.00.

For an analyst ratings summary and ratings history on Fate Therapeutics click here. For more ratings news on Fate Therapeutics click here.

Shares of Fate Therapeutics closed at $3.18 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

New Coverage

Related Entities

Roth Capital

Add Your Comment